Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|August 3, 2023
7 New Approved Drugs for Primary Care: Q2 2023
Author(s)Sydney Jennings
The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?
Advertisement
Another quarter has come and gone, which means Patient Care Online has compiled another list of new drugs approved by the US Food and Drug Administration (FDA) for conditions that are often seen in primary care. Scroll through the slides below to find details on the first oral antiviral pill approved by the FDA for the treatment of COVID-19 in adults, a novel formulation of rizatriptan benzoate for acute migraine treatment, the first vaccine against respiratory syncytial virus, and 4 more.
Advertisement
Related to this article
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Advertisement
Advertisement
Trending on Patient Care Online
1
ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms
2
Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A
3
Actigraphy and Objective Sleep Outcomes in Menopause VMS Treatment
4
Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease
5